Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

  


IPC STATEMENT
on SARS-CoV-2 Vaccines and Psoriasis
 

Six key take-aways that physicians and other healthcare practitioners should consider when administering the SARS-CoV-2 vaccine to psoriasis patients.

READ FULL STATEMENT


The National Psoriasis Foundation
COVID-19 Task Force Guidance Statements

Twenty-five key recommendations for the management of patients with psoriatic disease during the COVID-19 pandemic.


READ STATEMENTS


THIS WEEKS' PUBLICATIONS ON COVID-19 & PSORIASIS

No abstract
No abstract
No abstract
No abstract
Dear Editor, Various cutaneous manifestations have been reported with COVID-19 infections during the pandemic, with some reports of new onset or flares of pre-existing skin disease after roll out of the vaccination programmes¹ . We present a case of new onset generalised pustular psoriasis felt to be secondary to the Oxford-AstraZeneca COVID-19 vaccine.

VIEW ALL ON PUBMED

RECOURCES FROM OUR INDUSTRY PARTNERS

 AbbVie
Amgen
Novartis
UCB

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK